Literature DB >> 29779103

Dopamine Synthesis as a Mechanism of Brain Plasticity in Nigrostriatal System Pathology.

A A Kolacheva1, M V Ugrumov2.   

Abstract

Using an experimental Parkinson's disease model (symptoms develop in mice after the injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), we studied the characteristics of the synthesis of dopamine as a possible compensatory mechanism aimed at maintaining the dopamine level in the dopaminergic neurons that survived in this pathology. We found no correlation between the content and activity of tyrosine hydroxylase in the nigrostriatal system. The enzyme activity and the dopamine content showed unidirectional changes in the substantia nigra, but not in the striatum, which is apparently due to triggering other compensatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29779103     DOI: 10.1134/S1607672918020096

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  13 in total

Review 1.  Parkinson's disease: pathophysiology.

Authors:  Y Agid
Journal:  Lancet       Date:  1991-06-01       Impact factor: 79.321

2.  Protocol for the MPTP mouse model of Parkinson's disease.

Authors:  Vernice Jackson-Lewis; Serge Przedborski
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.

Authors:  Francesco Fornai; Oliver M Schlüter; Paola Lenzi; Marco Gesi; Riccardo Ruffoli; Michela Ferrucci; Gloria Lazzeri; Carla L Busceti; Fabrizio Pontarelli; Giuseppe Battaglia; Antonio Pellegrini; Ferdinando Nicoletti; Stefano Ruggieri; Antonio Paparelli; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-16       Impact factor: 11.205

4.  ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.

Authors:  Michael F Salvatore
Journal:  J Neurochem       Date:  2014-01-27       Impact factor: 5.372

5.  In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain.

Authors:  A Carlsson; M Lindqvist
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

6.  Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.

Authors:  H Tanji; T Araki; H Nagasawa; Y Itoyama
Journal:  Brain Res       Date:  1999-04-10       Impact factor: 3.252

7.  Modeling of presymptomatic and symptomatic stages of parkinsonism in mice.

Authors:  M V Ugrumov; V G Khaindrava; E A Kozina; V G Kucheryanu; E V Bocharov; G N Kryzhanovsky; V S Kudrin; V B Narkevich; P M Klodt; K S Rayevsky; T S Pronina
Journal:  Neuroscience       Date:  2011-03-05       Impact factor: 3.590

8.  The mouse MPTP model: gene expression changes in dopaminergic neurons.

Authors:  Kati Kühn; Jennifer Wellen; Nina Link; Lyutha Maskri; Hermann Lübbert; Christine C Stichel
Journal:  Eur J Neurosci       Date:  2003-01       Impact factor: 3.386

9.  Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases.

Authors:  T Nagatsu; T Yamaguchi; M K Rahman; J Trocewicz; K Oka; Y Hirata; I Nagatsu; H Narabayashi; T Kondo; R Iizuka
Journal:  Adv Neurol       Date:  1984

10.  Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  J Ara; S Przedborski; A B Naini; V Jackson-Lewis; R R Trifiletti; J Horwitz; H Ischiropoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  1 in total

1.  Pretreatment with Human Lactoferrin Had a Positive Effect on the Dynamics of Mouse Nigrostriatal System Recovery after Acute MPTP Exposure.

Authors:  Marina Yu Kopaeva; Anton B Cherepov; Mikhail V Nesterenko; Irina Yu Zarayskaya
Journal:  Biology (Basel)       Date:  2021-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.